← Open Payments lookup

CYNTHIA BANWELL: Open Payments

NPI 1124704911 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,358 in 71 payments from 14 companies in 2025. Trend: 2023 $220 · 2024 $1,131 · 2025 $1,358

Food & beverage: $1,358
CompanyPaymentsAmount
ABBVIE INC.19$311
Otsuka America Pharmaceutical, Inc.12$234
Axsome Therapeutics, Inc.4$142
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$142
Lundbeck LLC5$95
Vanda Pharmaceuticals Inc.5$83
E.R. Squibb & Sons, L.L.C.2$59
Supernus Pharmaceuticals, Inc.3$57
Collegium Pharmaceutical, Inc.3$54
Takeda Pharmaceuticals U.S.A., Inc.3$50

Products named: VRAYLAR, REXULTI, Auvelity, CAPLYTA, FANAPT, COBENFY, Qelbree, Jornay PM.

Industry payments across TX — which companies pay providers there.